Pacer Advisors Inc. lowered its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 99.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 36,186 shares of the company’s stock after selling 4,254,464 shares during the quarter. Pacer Advisors Inc.’s holdings in Cardinal Health were worth $4,280,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Paragon Capital Management Inc. raised its holdings in Cardinal Health by 0.7% in the 2nd quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company’s stock valued at $1,451,000 after buying an additional 99 shares during the period. Huntington National Bank lifted its holdings in shares of Cardinal Health by 0.9% in the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after acquiring an additional 100 shares during the last quarter. Frazier Financial Advisors LLC boosted its position in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares during the period. UMB Bank n.a. increased its holdings in Cardinal Health by 4.9% in the 3rd quarter. UMB Bank n.a. now owns 2,249 shares of the company’s stock valued at $249,000 after purchasing an additional 106 shares during the last quarter. Finally, Raleigh Capital Management Inc. raised its position in Cardinal Health by 29.6% in the fourth quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock valued at $55,000 after purchasing an additional 106 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on CAH shares. Deutsche Bank Aktiengesellschaft boosted their price objective on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday, November 4th. UBS Group increased their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Citigroup lifted their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a report on Friday, January 10th. Mizuho started coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price target for the company. Finally, TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $130.00 to $144.00 in a research report on Wednesday, January 8th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $135.21.
Cardinal Health Price Performance
NYSE CAH opened at $128.32 on Friday. The firm’s fifty day moving average price is $122.00 and its 200 day moving average price is $113.85. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $132.84. The company has a market capitalization of $31.05 billion, a price-to-earnings ratio of 24.96, a price-to-earnings-growth ratio of 1.57 and a beta of 0.63.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.
Cardinal Health Cuts Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were given a dividend of $0.5056 per share. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.58%. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
- Five stocks we like better than Cardinal Health
- 3 REITs to Buy and Hold for the Long Term
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Quiet Period Expirations Explained
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Market Cap Calculator: How to Calculate Market Cap
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.